Skip to main content

Table 1 Correlation between SNHG29 expression and clinical features (n = 33)

From: SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathway

Variable

SNHG29 Expression

P value

Low

High

Age

 < 50

10

12

0.721

 ≥ 50

6

5

Gender

 Male

9

8

0.731

 Female

7

9

Tumor size

0.005**

 < 5

12

4

 ≥ 5

4

13

 

WHO grade

0.01*

 I–II

9

2

 III–IV

7

15

 
  1. Low/high by the sample median. Pearson χ2 test. **P < 0.01, *P < 0.05 was considered to be statistically significant
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us